🔗 References (max. 100)
| part | subject | predicate | object | published by | date | |
|---|---|---|---|---|---|---|
|
Assertion
|
Felbamate oral suspension is recommended for use only in those patients who respond inadequately to alternative treatments and whose epilepsy is so severe that a substantial risk of aplastic anemia and/or liver failure is deemed acceptable in light of the benefits conferred by its use
|
|
||||
|
Assertion
|
|
|||||
|
Assertion
|
|